aTyr Pharma(LIFE)

Search documents
PesoRama Announces $5 Million LIFE Offering
Newsfile· 2025-06-10 11:18
Toronto, Ontario--(Newsfile Corp. - June 10, 2025) - PesoRama Inc. (TSXV: PESO) (OTC Pink: PSSOF) (FSE: ZE6) ("PesoRama" or the "Company"), a Canadian company operating dollar stores in Mexico under the JOi Dollar Plus brand, is pleased to announce a non-brokered private placement of 33,333,333 units of the Company (each, a "Unit") at a price of $0.15 per Unit (the "Offering Price") for gross proceeds of up to $5,000,000 (the "LIFE Offering") pursuant to the Listed Issuer Financing Exemption under Part 5A ...
Ucore Announces Books Closed on C$15.5 Million LIFE Offering and Full Exercise of Agents' Option
Newsfile· 2025-06-10 10:54
Halifax, Nova Scotia--(Newsfile Corp. - June 10, 2025) - Ucore Rare Metals Inc. (TSXV: UCU) (OTCQX: UURAF) ("Ucore" or the "Company") is pleased to announce that, further to its news release dated June 9, 2025, the order book for the Company's previously announced upsized private placement (the "Offering"), is closed with orders totaling C$15.5 million. The Offering is over-subscribed and includes the full exercise of the agents' option. Although orders in excess of C$15.5 million were received in connecti ...
Argyle Closes C$1 Million LIFE Offering
Newsfile· 2025-06-09 20:00
Calgary, Alberta--(Newsfile Corp. - June 9, 2025) - Argyle Resources Corp. (CSE: ARGL) (OTCQB: ARLYF) (FSE: ME0) ("Argyle" or the "Company") is pleased to announce that it has closed its previously announced offering of 2,000,000 units of the Company ("Units") at a price of C$0.50 per Unit, for aggregate gross proceeds up to C$1,000,000 (the "Offering"). Each Unit is comprised of one common share in the authorized share structure of the Company (a "Share") plus one-half of one Share purchase warrant (each ...
Defiance Silver Corp. Announces Upsize of the Brokered LIFE Offering and Non-Brokered Private Placement for Aggregate Gross Proceeds of up to C$14.5 Million
Newsfile· 2025-06-05 19:16
Defiance Silver Corp. Announces Upsize of the Brokered LIFE Offering and Non-Brokered Private Placement for Aggregate Gross Proceeds of up to C$14.5 MillionJune 05, 2025 3:16 PM EDT | Source: Defiance Silver Corp.Vancouver, British Columbia--(Newsfile Corp. - June 5, 2025) - Defiance Silver Corp. (TSXV: DEF) (FSE: D4E) (WKN: A1JQW5) (the "Company", or "Defiance") is pleased to announce that, as a result of strong investor demand, the Company has increased the size of its previously announced " ...
Defiance Silver Corp. Announces Brokered LIFE Offering for Gross Proceeds of up to C$8 Million
Newsfile· 2025-06-04 21:23
Core Viewpoint - Defiance Silver Corp. has announced a brokered private placement offering to raise gross proceeds of up to C$8 million through the sale of up to 32 million units at a price of C$0.25 per unit [1][2]. Group 1: Offering Details - Each unit will consist of one common share and one-half of a common share purchase warrant, with each whole warrant allowing the purchase of one common share at a price of C$0.35 within 24 months following the closing date [2]. - The company grants the agent an option to sell up to an additional 8 million units for additional gross proceeds of up to C$2 million [3]. - The offering is scheduled to close on June 17, 2025, subject to regulatory approvals [8][9]. Group 2: Use of Proceeds - The net proceeds from the offering will be used for exploration work on the company's projects, completing a mineral resource estimate at the San Acacio project, making cash option payments on the Tepal project, and providing general working capital [4]. Group 3: Regulatory Compliance - The units will be offered to purchasers in specific Canadian provinces under the Listed Issuer Financing Exemption, and may also be sold in offshore jurisdictions and the United States under applicable exemptions [5][7]. - All securities not issued under the Listed Issuer Financing Exemption will be subject to a hold period of four months and one day following the closing date [7]. Group 4: Company Overview - Defiance Silver Corp. is focused on advancing the Zacatecas project and the Tepal Gold/Copper Project in Mexico, managed by a team with a proven track record in mine development [11].
Ucore Announces Brokered LIFE Offering of Units for up to $10 Million
Newsfile· 2025-06-03 20:30
Core Viewpoint - Ucore Rare Metals Inc. has initiated a private placement offering to raise up to $10 million, with the potential to increase to $11.5 million if the Agents' Option is fully exercised, aimed at advancing its strategic metals complex and fulfilling obligations with the U.S. Department of Defense and Natural Resources Canada [1][2][5]. Group 1: Offering Details - The offering price is set at $1.20 per Unit, with each Unit comprising one common share and one-half of a warrant, allowing the purchase of one common share at an exercise price of $1.75 for 36 months [1]. - The Agents' Option allows for the sale of an additional 1,250,000 Units, potentially raising an extra $1.5 million [2]. - The offering is expected to close around June 19, 2025, pending necessary approvals [7]. Group 2: Use of Proceeds - Proceeds from the offering will be allocated to finalizing upstream mixed-rare-earth feedstock agreements and downstream customer offtake agreements for the planned strategic metals complex in Louisiana [5]. - Funds will also support the completion of existing obligations with the U.S. Department of Defense and Natural Resources Canada, commercial scale column confirmation testing, and ongoing engineering plans for the strategic metals complex [5]. Group 3: Regulatory and Market Context - The Units will be offered under the listed issuer financing exemption in Canada, excluding Québec, and will not have resale restrictions under applicable Canadian securities laws [3]. - The offering will also be available in the United States under exemptions from registration requirements, with no prospectus filing obligations in other jurisdictions [4]. Group 4: Company Overview - Ucore focuses on rare and critical metal resources, aiming to become a leading advanced technology company in metal separation products and services [11]. - The company plans to disrupt China's control over the North American rare earth element supply chain through the development of processing facilities in the U.S. and Canada [12].
Argyle Announces up to C$1 Million LIFE Offering
Newsfile· 2025-05-26 23:00
Core Points - Argyle Resources Corp. plans to complete an offering of up to 2,000,000 units at a price of C$0.50 per unit, aiming for gross proceeds of up to C$1,000,000 [1] - Each unit consists of one common share and one-half of a share purchase warrant, with the warrant allowing the purchase of one share at C$0.55 for 24 months [1] - The offering will be conducted under the listed issuer financing exemption, allowing for no resale restrictions in most Canadian provinces [2] Financial Details - The offering is scheduled to close on or about June 6, 2025, and is subject to raising a minimum of C$750,000 [4] - Proceeds from the offering will be used for general working capital purposes [4] Company Overview - Argyle Resources Corp. is a junior mineral exploration company focused on acquiring and evaluating natural resource properties in North America [6] - The company holds a 100% interest in several silica projects in Québec and has options to acquire additional properties in Ontario and Nova Scotia [6] - Established in 2023, the company is headquartered in Calgary, Alberta [7]
aTyr Pharma(LIFE) - 2025 Q1 - Quarterly Report
2025-05-07 20:07
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37378 ATYR PHARMA, INC. (Exact name of registrant as specified in its charter) Delaware 20-3435077 (State or other jurisdiction ...
aTyr Pharma(LIFE) - 2025 Q1 - Quarterly Results
2025-05-07 20:03
Exhibit 99.1 IMMEDIATE RELEASE Contact: Ashlee Dunston Sr. Director, Investor Relations and Public Affairs adunston@atyrpharma.com aTyr Pharma Announces First Quarter 2025 Results and Provides Corporate Update Topline data from Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis on track for the third quarter of 2025. Blinded baseline demographics and disease characteristics from Phase 3 EFZO-FIT™ study and current U.S. epidemiology and treatment practices for pulmonary sarcoidosis to be present ...
GLOBE LIFE INC. REPORTS FIRST QUARTER 2025 RESULTS
Prnewswire· 2025-04-30 20:15
MCKINNEY, Texas, April 30, 2025 /PRNewswire/ -- Globe Life Inc. (NYSE: GL) reported today that for the quarter ended March 31, 2025, net income was $3.01 per diluted common share, compared with $2.67 per diluted common share for the year-ago quarter. Net operating income was $3.07 per diluted common share, above management's expectations, compared with $2.78 per diluted common share for the year-ago quarter.HIGHLIGHTS: Net income as an ROE was 19.0% for the three months ended March 31, 2025. Net operating i ...